Monsters have haunted the human imagination since time immemorial. But how well do you actually know your creepers, crawlers, and midnight maulers? Test your kn ...
Freenome will present results Oct. 14 at ACG 2026; sensitivity for lesions with high-grade dysplasia was 41.9%, versus 30.5% ...
FDA accepted BridgeBio’s encaleret NDA, granting Priority Review and setting a May 8, 2027 target action date; RECLAIM-HP has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results